Clinical Data Announces Renewed DNA Sequencing Contract with MRC
News Jun 06, 2006
The Company's Cogenics division (formerly Lark Technologies) is UK based provider of DNA sequencing to pharmaceutical, biotech and academic institutes with a long history of working with the MRC.
Paul Tomlin, Director of European Operations, said, "We are very pleased to continue our relationship with the MRC and are confident of meeting the needs of MRC scientists across all 35 UK sites."
"Cogenics has over 17 years experience with DNA sequencing and other molecular biology services and as such is uniquely positioned to provide the best customer experience possible and to serve the needs of the MRC."
Cogenics provides comprehensive pharmacogenomics and molecular services to the scientific community with six sites across North America and Europe employing over 200 experienced scientists and other professionals.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018